Medipower 0.1$(IL:MDPR)
ILAÂ 440.00-6.40 (-1.43%)
IL:MDPR
Medipower 0.1$ financials statements
ILAÂ 440.00
At close:-6.40 (-1.43%)
Medipower 0.1$ (MDPR) Ratios
0 Followers
Medipower 0.1$ Ratios
IL:MDPR's free cash flow for Q2 2026 was $2.43M. For the 2026 fiscal year, IL:MDPR's free cash flow was increased by $0.00 and operating cash flow was $2.43M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.67 | 0.00 | 2.91 | 2.59 | 1.94 |
| Quick Ratio | 2.67 | 0.00 | 2.91 | 2.59 | 1.94 |
| Cash Ratio | 2.57 | 0.00 | 2.91 | 2.59 | 1.94 |
| Solvency Ratio | 0.04 | 0.04 | -0.06 | -0.07 | -0.03 |
| Operating Cash Flow Ratio | 0.61 | 0.00 | 6.56 | 4.76 | 4.50 |
| Short-Term Operating Cash Flow Coverage | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -303.46M | $ -224.83M | $ -269.88M | $ -281.45M | $ -287.70M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.64 | 0.56 | 0.57 | 0.60 | 0.61 |
| Debt-to-Equity Ratio | 2.40 | 1.74 | 1.91 | 2.20 | 2.56 |
| Debt-to-Capital Ratio | 0.71 | 0.64 | 0.66 | 0.69 | 0.72 |
| Long-Term Debt-to-Capital Ratio | 0.69 | 0.64 | 0.66 | 0.69 | 0.72 |
| Financial Leverage Ratio | 3.75 | 3.12 | 3.37 | 3.68 | 4.21 |
| Debt Service Coverage Ratio | 0.73 | 9.19 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 2.13 | 2.59 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 3.18 | 2.60 | 2.84 | 3.03 | 2.81 |
| Interest Debt Per Share | 7.12 | 4.74 | 4.62 | 4.95 | 5.84 |
| Net Debt to EBITDA | 7.50 | 2.40 | -17.10 | -12.65 | -41.17 |
| Profitability Margins | |||||
| Gross Profit Margin | 66.80% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | 82.40% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 82.40% | 241.46% | -34.96% | -51.43% | -19.00% |
| Operating Profit Margin | 60.19% | 65.44% | 48.47% | 42.16% | 91.46% |
| Pretax Profit Margin | 54.14% | 39.33% | 26.63% | 17.17% | 54.12% |
| Net Profit Margin | 30.07% | 26.00% | 20.72% | 3.58% | 29.83% |
| Continuous Operations Profit Margin | 39.40% | 30.31% | 21.28% | 11.92% | 40.45% |
| Net Income Per EBT | 55.54% | 66.09% | 77.83% | 20.87% | 55.13% |
| EBT Per EBIT | 89.95% | 60.10% | 54.94% | 40.73% | 59.17% |
| Return on Assets (ROA) | 2.45% | 2.45% | 1.92% | 0.32% | 2.28% |
| Return on Equity (ROE) | 9.20% | 7.64% | 6.48% | 1.18% | 9.61% |
| Return on Capital Employed (ROCE) | 5.19% | 6.16% | 4.51% | 3.79% | 7.03% |
| Return on Invested Capital (ROIC) | 3.58% | 4.33% | 3.61% | 2.88% | 5.88% |
| Return on Tangible Assets | 2.45% | 2.45% | 1.92% | 0.32% | 2.28% |
| Earnings Yield | 12.16% | 11.37% | 9.62% | 1.62% | 10.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 14.94 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 77.88 | 0.10 | 0.10 | 0.10 | 0.09 |
| Asset Turnover | 0.08 | 0.09 | 0.09 | 0.09 | 0.08 |
| Working Capital Turnover Ratio | 1.01 | 1.80 | 9.88 | 11.90 | 4.80 |
| Cash Conversion Cycle | 24.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 24.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 24.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.35 | 0.31 | 0.23 | 0.25 | 0.23 |
| Free Cash Flow Per Share | 0.35 | 0.31 | 0.23 | 0.25 | 0.23 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 153.90 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 153.90 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.05 | 0.07 | 0.05 | 0.05 | 0.04 |
| Operating Cash Flow to Sales Ratio | 0.40 | 0.40 | 0.31 | 0.34 | 0.31 |
| Free Cash Flow Yield | 16.07% | 17.70% | 14.43% | 15.49% | 10.90% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 8.33 | 8.75 | 10.39 | 61.65 | 9.48 |
| Price-to-Sales (P/S) Ratio | 2.47 | 2.29 | 2.15 | 2.21 | 2.83 |
| Price-to-Book (P/B) Ratio | 0.76 | 0.67 | 0.67 | 0.73 | 0.91 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.22 | 5.65 | 6.93 | 6.46 | 9.17 |
| Price-to-Operating Cash Flow Ratio | 6.22 | 5.65 | 6.93 | 6.41 | 9.17 |
| Price-to-Earnings Growth (PEG) Ratio | 0.28 | 0.35 | 0.02 | -0.70 | 0.04 |
| Enterprise Value Multiple | 10.50 | 3.35 | -23.27 | -16.94 | -56.06 |
| Enterprise Value | 387.72M | 316.44M | 314.13M | 327.09M | 328.01M |
| EV to EBITDA | 10.50 | 3.35 | -23.27 | -16.94 | -56.06 |
| EV to Sales | 8.66 | 8.08 | 8.13 | 8.71 | 10.65 |
| EV to Free Cash Flow | 21.78 | 19.96 | 26.18 | 25.47 | 34.52 |
| EV to Operating Cash Flow | 21.78 | 19.96 | 26.18 | 25.30 | 34.52 |
| Tangible Book Value Per Share | 3.28 | 2.96 | 2.76 | 2.60 | 2.65 |
| Shareholders’ Equity Per Share | 2.86 | 2.60 | 2.42 | 2.25 | 2.28 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.27 | 0.23 | 0.20 | 0.31 | 0.25 |
| Revenue Per Share | 0.88 | 0.77 | 0.76 | 0.74 | 0.73 |
| Net Income Per Share | 0.26 | 0.20 | 0.16 | 0.03 | 0.22 |
| Tax Burden | 0.56 | 0.66 | 0.78 | 0.21 | 0.55 |
| Interest Burden | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.07 | 0.07 | 0.07 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.32 | 1.56 | 1.50 | 9.61 | 1.03 |
Currency in USD
